CanSino Biologics Inc is a CN-based company operating in Biotechnology industry. The company is headquartered in Tianjin, Tianjin and currently employs 1,105 full-time employees. The company went IPO on 2019-03-28. CanSino Biologics Inc is a China-based company primarily engaged in the research and development, production, and commercialization of human vaccine products. The Company’s products and product pipeline under research include multiple vaccine varieties such as meningitis, pneumonia, diphtheria, tetanus, and pertussis (DPT), coronavirus disease 2019 (COVID-19), Ebola virus disease, poliomyelitis, herpes zoster, tuberculosis and others. The firm is also engaged in the research and development of pharmaceutical production processes. The firm conducts its business in the domestic and overseas markets.
06185.HK stock price ended at $35.74 on 星期四, after rising 0.11%
On the latest trading day Jan 22, 2026, the stock price of 06185.HK rose by 0.11%, climbing from $36.14 to $35.74. Throughout the session, the stock experienced a volatility of 1.74%, with prices fluctuating between a daily low of $35.68 and a high of $36.30. Alongside this price increase, trading volume also rose by 184.2K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 171.6K shares were traded, amounting to a market value of approximately $4.7B.